Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease
MS Wathen, MO Sweeney, PJ DeGroot, AJ Stark… - Circulation, 2001 - Am Heart Assoc
Background Implantable cardioverter-defibrillators (ICDs) can terminate some ventricular
tachycardias (VTs) painlessly with antitachycardia pacing (ATP). ATP has not routinely been …
tachycardias (VTs) painlessly with antitachycardia pacing (ATP). ATP has not routinely been …
Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable …
MS Wathen, PJ DeGroot, MO Sweeney, AJ Stark… - Circulation, 2004 - Am Heart Assoc
Background—Successful antitachycardia pacing (ATP) terminates ventricular tachycardia
(VT) up to 250 bpm without the need for painful shocks in implantable cardioverter …
(VT) up to 250 bpm without the need for painful shocks in implantable cardioverter …
A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter …
MM Gulizia, L Piraino, M Scherillo… - Circulation …, 2009 - Am Heart Assoc
Background—In patients with implantable cardioverter-defibrillators (ICDs), antitachycardia
pacing (ATP) is highly effective in terminating fast ventricular tachycardias (FVTs) and lowers …
pacing (ATP) is highly effective in terminating fast ventricular tachycardias (FVTs) and lowers …
Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: a prospective study including 200 patients
A Schaumann, F Mühlen, B Herse, BD Gonska… - Circulation, 1998 - Am Heart Assoc
Background—Implantable cardioverter-defibrillators (ICDs) reduce the risk of sudden
cardiac death. The objective of this study was to evaluate whether testing of antitachycardia …
cardiac death. The objective of this study was to evaluate whether testing of antitachycardia …
Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III …
M Gasparini, A Proclemer, C Klersy, A Kloppe, M Lunati… - Jama, 2013 - jamanetwork.com
Importance Using more intervals to detect ventricular tachyarrhythmias has been associated
with reducing unnecessary implantable cardioverter-defibrillator (ICD) therapies. Objective …
with reducing unnecessary implantable cardioverter-defibrillator (ICD) therapies. Objective …
Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapy
Implantable defibrillators reduce the risk of sudden death in patients with malignant
ventricular arrhythmias, but significant restriction in quality of life can occur as a result of …
ventricular arrhythmias, but significant restriction in quality of life can occur as a result of …
A prospective randomized comparison of autodecremental pacing to burst pacing in device therapy for chronic ventricular tachycardia secondary to coronary artery …
AM Gillis, JW Leitch, RS Sheldon, CA Morillo… - The American journal of …, 1993 - Elsevier
A number of modes of antitachycardia pacing therapies are available in the newer
generations of implantable cardioverter/defibrillators. The efficacy of synchronized burst …
generations of implantable cardioverter/defibrillators. The efficacy of synchronized burst …
Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator …
MO Sweeney, MS Wathen, K Volosin, I Abdalla… - Circulation, 2005 - Am Heart Assoc
Background—Implantable cardioverter defibrillators (ICDs) reduce mortality in primary and
secondary prevention. Quality of life, mortality, appropriate therapies for specific ventricular …
secondary prevention. Quality of life, mortality, appropriate therapies for specific ventricular …
Ventricular tachycardias above the initially programmed tachycardia detection interval in patients with implantable cardioverter-defibrillators: incidence, prediction and …
D Bänsch, M Castrucci, D Böcker, G Breithardt… - Journal of the American …, 2000 - jacc.org
OBJECTIVES This retrospective study was performed to provide data on ventricular
tachycardias (VT) with a cycle length longer than the initially programmed tachycardia …
tachycardias (VT) with a cycle length longer than the initially programmed tachycardia …
Efficacy and safety of appropriate shocks and antitachycardia pacing in transvenous and subcutaneous implantable defibrillators: analysis of all appropriate therapy in …
RE Knops, W Van Der Stuijt, PPHM Delnoy… - Circulation, 2022 - Am Heart Assoc
Background: The PRAETORIAN trial (A Prospective, Randomized Comparison of
Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy) showed …
Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy) showed …
相关搜索
- ventricular tachycardia artery disease
- ventricular tachycardia shock reduction
- shock reduction artery disease
- antitachycardia pacing defibrillator shocks
- ventricular tachycardia autodecremental pacing
- autodecremental pacing artery disease
- ventricular tachycardias cardioverter defibrillators
- antitachycardia pacing implantable device
- ventricular tachycardia device therapy
- device therapy artery disease
- antitachycardia pacing shock delivery
- antitachycardia pacing shock therapy
- antitachycardia pacing cardioverter defibrillators